Autocrine vitamin D signaling switches off pro-inflammatory programs of T
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
/ metabolism
Basic-Leucine Zipper Transcription Factors
/ metabolism
Bronchoalveolar Lavage Fluid
/ cytology
COVID-19
/ immunology
Complement C3a
/ immunology
Complement C3b
/ immunology
Humans
Interferon-gamma
/ immunology
Interleukin-10
/ immunology
JNK Mitogen-Activated Protein Kinases
/ metabolism
Lymphocyte Activation
/ immunology
Receptors, Calcitriol
/ metabolism
Respiratory Distress Syndrome
/ immunology
SARS-CoV-2
/ immunology
STAT3 Transcription Factor
/ metabolism
Signal Transduction
/ immunology
Th1 Cells
/ immunology
Transcription, Genetic
/ genetics
Vitamin D
/ metabolism
Journal
Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
23
07
2020
accepted:
26
10
2021
pubmed:
13
11
2021
medline:
12
1
2022
entrez:
12
11
2021
Statut:
ppublish
Résumé
The molecular mechanisms governing orderly shutdown and retraction of CD4
Identifiants
pubmed: 34764490
doi: 10.1038/s41590-021-01080-3
pii: 10.1038/s41590-021-01080-3
pmc: PMC7612139
mid: EMS137571
doi:
Substances chimiques
BACH2 protein, human
0
Basic-Leucine Zipper Transcription Factors
0
IFNG protein, human
0
IL10 protein, human
0
Receptors, Calcitriol
0
STAT3 Transcription Factor
0
STAT3 protein, human
0
VDR protein, human
0
Interleukin-10
130068-27-8
Vitamin D
1406-16-2
Complement C3a
80295-42-7
Complement C3b
80295-43-8
Interferon-gamma
82115-62-6
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
EC 1.14.15.18
CYP27B1 protein, human
EC 1.14.15.18
JNK Mitogen-Activated Protein Kinases
EC 2.7.11.24
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
62-74Subventions
Organisme : British Heart Foundation
ID : RG/13/12/30395
Pays : United Kingdom
Organisme : Wellcome Trust (Wellcome)
ID : 097261/Z/11/Z
Organisme : U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
ID : ZIA/Hl006223
Organisme : Crohn's and Colitis Foundation (Crohn's & Colitis Foundation)
ID : CCFA no. 3765
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
ID : DK12262401A1
Organisme : NIDDK NIH HHS
ID : R01 DK122624
Pays : United States
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : FR 3851/2-1
Organisme : U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
ID : ZIA/HL006193
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
ID : ZIA/DK075149
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : ZIA/AI00117
Organisme : British Heart Foundation (BHF)
ID : RG/13/12/30395
Organisme : NIGMS NIH HHS
ID : R35 GM138283
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
ID : R35GM138283
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : ZIA/AI001175
Organisme : U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
ID : ZIA/Hl00622
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
Références
RECOVERY Collaborative Group et al.Dexamethasone in hospitalized patients with COVID-19. New Engl. J. Med. 384, 693–704 (2020).
doi: 10.1056/NEJMoa2021436
Gazzinelli, R. T. et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4
pubmed: 8752931
doi: 10.4049/jimmunol.157.2.798
Noris, M. & Remuzzi, G. Overview of complement activation and regulation. Semin. Nephrol. 33, 479–492 (2013).
pubmed: 24161035
pmcid: 3820029
doi: 10.1016/j.semnephrol.2013.08.001
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V. & Roumenina, L. T. Complement system part I – molecular mechanisms of activation and regulation. Front. Immunol. 6, 262 (2015).
pubmed: 26082779
pmcid: 4451739
doi: 10.3389/fimmu.2015.00262
Robbins, R. A., Russ, W. D., Rasmussen, J. K. & Clayton, M. M. Activation of the complement system in the adult respiratory distress syndrome 1–4. Am. Rev. Respir. Dis. 135, 651–658 (1987).
pubmed: 3826891
Ohta, R. et al. Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza. Microbiol. Immunol. 55, 191–198 (2011).
pubmed: 21244468
doi: 10.1111/j.1348-0421.2011.00309.x
Carvelli, J. et al. Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis. Nature https://doi.org/10.1038/s41586-020-2600-6 (2020).
Sinkovits, G. et al. Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection. Front. Immunol. 12, 663187 (2021).
pubmed: 33841446
pmcid: 8027327
doi: 10.3389/fimmu.2021.663187
Ramlall, V. et al. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat. Med. 26, 1609–1615 (2020).
pubmed: 32747830
pmcid: 7809634
doi: 10.1038/s41591-020-1021-2
Rockx, B. et al. Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. J. Virol. 83, 7062–7074 (2009).
pubmed: 19420084
pmcid: 2704758
doi: 10.1128/JVI.00127-09
Mastaglio, S. et al. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin. Immunol. 215, 108450 (2020).
pubmed: 32360516
pmcid: 7189192
doi: 10.1016/j.clim.2020.108450
Liszewski, M. K. et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity 39, 1143–1157 (2013).
pubmed: 24315997
pmcid: 3865363
doi: 10.1016/j.immuni.2013.10.018
Yan, B. et al. SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation. Sci. Immunol. 6, eabg0833 (2021).
pubmed: 33827897
pmcid: 8139422
doi: 10.1126/sciimmunol.abg0833
West, E. E., Kolev, M. & Kemper, C. Complement and the regulation of T cell responses. Annu Rev. Immunol. 36, 309–338 (2018).
pubmed: 29677470
pmcid: 7478175
doi: 10.1146/annurev-immunol-042617-053245
Break, T. J. et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science 371, eaay5731 (2021).
pubmed: 33446526
pmcid: 8326743
doi: 10.1126/science.aay5731
Cardone, J. et al. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 11, 862–871 (2010).
pubmed: 20694009
pmcid: 4011020
doi: 10.1038/ni.1917
Yamshchikov, A., Desai, N., Blumberg, H., Ziegler, T. & Tangpricha, V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr. Pr. 15, 438–449 (2009).
doi: 10.4158/EP09101.ORR
Holick, M. F. Vitamin D deficiency. N. Engl. J. Med. 357, 266–281 (2007).
pubmed: 17634462
doi: 10.1056/NEJMra070553
Akbar, M. R., Wibowo, A., Pranata, R. & Setiabudiawan, B. Low serum 25-hydroxyvitamin D (vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: a systematic review and meta-analysis. Front. Nutr. 8, 660420 (2021).
pubmed: 33855042
pmcid: 8039288
doi: 10.3389/fnut.2021.660420
Zhao, J. et al. Airway memory CD4(
pubmed: 27287409
pmcid: 4917442
doi: 10.1016/j.immuni.2016.05.006
Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463–469 (2020).
pubmed: 32717743
pmcid: 7477538
doi: 10.1038/s41586-020-2588-y
Kolev, M. et al. Diapedesis-induced integrin signaling via LFA-1 facilitates tissue immunity by inducing intrinsic complement C3 expression in immune cells. Immunity 52, 513–527 (2020).
pubmed: 32187519
pmcid: 7111494
doi: 10.1016/j.immuni.2020.02.006
Magro, C. et al. Complement-associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl. Res. 220, 1–13 (2020).
pubmed: 32299776
pmcid: 7158248
doi: 10.1016/j.trsl.2020.04.007
Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489–1501 (2020).
pubmed: 32473127
pmcid: 7237901
doi: 10.1016/j.cell.2020.05.015
Sigmundsdottir, H. et al. DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nat. Immunol. 8, 285–293 (2007).
pubmed: 17259988
doi: 10.1038/ni1433
Veldman, C. M., Cantorna, M. T. & DeLuca, H. F. Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system. Arch. Biochem. Biophys. 374, 334–338 (2000).
pubmed: 10666315
doi: 10.1006/abbi.1999.1605
Chen, D.-J. et al. Altered microRNAs expression in T cells of patients with SLE involved in the lack of vitamin D. Oncotarget 8, 62099–62110 (2017).
pubmed: 28977929
pmcid: 5617489
doi: 10.18632/oncotarget.19062
Jeffery, L. E. et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 183, 5458–5467 (2009).
pubmed: 19843932
doi: 10.4049/jimmunol.0803217
Barrat, F. J. et al. In vitro generation of interleukin 10-producing regulatory CD4
pubmed: 11877483
pmcid: 2193760
doi: 10.1084/jem.20011629
Gagliani, N. et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 19, 739–746 (2013).
pubmed: 23624599
doi: 10.1038/nm.3179
Hunter, C. A. & Jones, S. A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448–457 (2015).
pubmed: 25898198
doi: 10.1038/ni.3153
Abani, O. et al. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 397, 1637–1645 (2021).
doi: 10.1016/S0140-6736(21)00676-0
Stumhofer, J. S. et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363–1371 (2007).
pubmed: 17994025
doi: 10.1038/ni1537
Jin, J.-O., Han, X. & Yu, Q. Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation. J. Autoimmun. 40, 28–44 (2013).
pubmed: 22921334
doi: 10.1016/j.jaut.2012.07.009
Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector T
pubmed: 16648838
doi: 10.1038/nature04753
Afzali, B. et al. BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency. Nat. Immunol. 18, 813–823 (2017).
pubmed: 28530713
pmcid: 5593426
doi: 10.1038/ni.3753
Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307–319 (2013).
pubmed: 23582322
pmcid: 3653129
doi: 10.1016/j.cell.2013.03.035
Roychoudhuri, R. et al. BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature 498, 506–510 (2013).
pubmed: 23728300
pmcid: 3710737
doi: 10.1038/nature12199
Povoleri, G. A. M. et al. Human retinoic acid–regulated CD161
pubmed: 30397350
pmcid: 6474659
doi: 10.1038/s41590-018-0230-z
Playford, M. P. et al. Serum active 1,25(OH)2D, but not inactive 25(OH)D vitamin D levels are associated with cardiometabolic and cardiovascular disease risk in psoriasis. Atherosclerosis 289, 44–50 (2019).
pubmed: 31450013
pmcid: 7428835
doi: 10.1016/j.atherosclerosis.2019.08.006
Armstrong, A. W. & Read, C. Pathophysiology, clinical presentation, and treatment of psoriasis. JAMA 323, 1945–1960 (2020).
pubmed: 32427307
doi: 10.1001/jama.2020.4006
Ghannam, A., Fauquert, J.-L., Thomas, C., Kemper, C. & Drouet, C. Human complement C3 deficiency: T
pubmed: 24321396
doi: 10.1016/j.molimm.2013.11.010
Schedel, M. et al. 1,25D3 prevents CD8
pubmed: 26750596
pmcid: 4712703
doi: 10.1038/ncomms10213
Song, J. et al. Vitamin D receptor restricts T helper 2-biased inflammation in the heart. Cardiovasc. Res. 114, 870–879 (2018).
pubmed: 29444238
doi: 10.1093/cvr/cvy034
Bohmann, D. et al. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238, 1386–1392 (1987).
pubmed: 2825349
doi: 10.1126/science.2825349
Tian, S. et al. Meta-analysis derived (MAD) transcriptome of psoriasis defines the ‘core’ pathogenesis of disease. PLoS ONE 7, e44274 (2012).
pubmed: 22957057
pmcid: 3434204
doi: 10.1371/journal.pone.0044274
Franke, A. et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat. Genet. 42, 1118–1125 (2010).
pubmed: 21102463
pmcid: 3299551
doi: 10.1038/ng.717
Yegorov, S., Bromage, S., Boldbaatar, N. & Ganmaa, D. Effects of vitamin D supplementation and seasonality on circulating cytokines in adolescents: analysis of data from a feasibility trial in Mongolia. Front. Nutr. 6, 166 (2019).
pubmed: 31709259
pmcid: 6819500
doi: 10.3389/fnut.2019.00166
Turksen, K., Kupper, T., Degenstein, L., Williams, I. & Fuchs, E. Interleukin 6: insights to its function in skin by overexpression in transgenic mice. Proc. Natl Acad. Sci. USA 89, 5068–5072 (1992).
pubmed: 1375756
pmcid: 49230
doi: 10.1073/pnas.89.11.5068
Lin, Z., Kondo, T., Ishida, Y., Takayasu, T. & Mukaida, N. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL‐6‐deficient mice. J. Leukoc. Biol. 73, 713–721 (2003).
pubmed: 12773503
doi: 10.1189/jlb.0802397
Wendling, D., Letho-Gyselinck, H., Guillot, X. & Prati, C. Psoriasis onset with tocilizumab treatment for rheumatoid arthritis. J. Rheumatol. 39, 657–657 (2012).
pubmed: 22383356
doi: 10.3899/jrheum.111166
Nogues, X. et al. Calcifediol treatment and COVID-19-related outcomes. J. Clin. Endocrinol. Metab. 106, dgab405 (2021).
doi: 10.1210/clinem/dgab405
Alcala-Diaz, J. F. et al. Calcifediol treatment and hospital mortality due to COVID-19: a cohort study. Nutrients 13, 1760 (2021).
pubmed: 34064175
pmcid: 8224356
doi: 10.3390/nu13061760
Kolev, M. et al. Complement regulates nutrient influx and metabolic reprogramming during T
pubmed: 26084023
pmcid: 4518498
doi: 10.1016/j.immuni.2015.05.024
Skene, P. J., Henikoff, J. G. & Henikoff, S. Targeted in situ genome-wide profiling with high efficiency for low cell numbers. Nat. Protoc. 13, 1006–1019 (2018).
pubmed: 29651053
doi: 10.1038/nprot.2018.015
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
pubmed: 22388286
pmcid: 3322381
doi: 10.1038/nmeth.1923
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
pubmed: 19505943
pmcid: 2723002
doi: 10.1093/bioinformatics/btp352
Zhang, Y. et al. Model-based analysis of ChIP-seq (MACS). Genome Biol. 9, R137 (2008).
pubmed: 18798982
pmcid: 2592715
doi: 10.1186/gb-2008-9-9-r137
Zhu, Q., Liu, N., Orkin, S. H. & Yuan, G.-C. CUT&RUNTools: a flexible pipeline for CUT&RUN processing and footprint analysis. Genome Biol. 20, 192 (2019).
pubmed: 31500663
pmcid: 6734249
doi: 10.1186/s13059-019-1802-4
Ramírez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160–W165 (2016).
pubmed: 27079975
pmcid: 4987876
doi: 10.1093/nar/gkw257
Kaya-Okur, H. S. et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat. Commun. 10, 1930 (2019).
pubmed: 31036827
pmcid: 6488672
doi: 10.1038/s41467-019-09982-5
Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinf. 12, 323 (2011).
doi: 10.1186/1471-2105-12-323
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
pubmed: 19910308
doi: 10.1093/bioinformatics/btp616
Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26, 842–844 (2020).
pubmed: 32398875
doi: 10.1038/s41591-020-0901-9
Reyfman, P. A. et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am. J. Resp. Crit. Care 199, 1517–1536 (2019).
doi: 10.1164/rccm.201712-2410OC
Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189–196 (2016).
pubmed: 27124452
pmcid: 4944528
doi: 10.1126/science.aad0501
Stuart, T. et al. Comprehensive Integration of single-cell data. Cell 177, 1888–1902 (2019).
pubmed: 31178118
pmcid: 6687398
doi: 10.1016/j.cell.2019.05.031
Wilk, A. J. et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 26, 1070–1076 (2020).
pubmed: 32514174
pmcid: 7382903
doi: 10.1038/s41591-020-0944-y
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
pubmed: 16199517
pmcid: 1239896
doi: 10.1073/pnas.0506580102
Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739–1740 (2011).
pubmed: 21546393
pmcid: 3106198
doi: 10.1093/bioinformatics/btr260
Liberzon, A. et al. The molecular signatures database hallmark gene set collection. Cell Syst. 1, 417–425 (2015).
pubmed: 26771021
pmcid: 4707969
doi: 10.1016/j.cels.2015.12.004
Stubbington, M. J. et al. An atlas of mouse CD4
pubmed: 25886751
pmcid: 4384382
doi: 10.1186/s13062-015-0045-x
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
pubmed: 14597658
pmcid: 403769
doi: 10.1101/gr.1239303
Krzywinski, M. et al. Circos: an information aesthetic for comparative genomics. Genome Res. 19, 1639–1645 (2009).
pubmed: 19541911
pmcid: 2752132
doi: 10.1101/gr.092759.109